Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2018-10-25 Major Shareholding Noti…
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Meldepliktig handel for primærinnsider
Major Shareholding Notification Classification · 99% confidence The document text is very short (478 characters) and reports on a transaction involving shares by a primary insider ('primærinnsider'), specifically a board member ('styremedlem') of Navamedic ASA. The content details the purchase of 18,000 shares and the resulting total holding (31.4456%). This directly corresponds to the definition of Director's Dealing (insider trades). Matching against definitions: - DIRS (Director's Dealing): Report of personal share transactions by company directors and executives (insider trades). This is a perfect match. - Other codes like ER, IR, 10-K are incorrect as this is not a financial performance report. - The document is the report itself, not an announcement of a report, so RPA/RNS is less specific than DIRS.
2018-10-25 Norwegian
Meldepliktig handel for primærinnsider
Director's Dealing Classification · 99% confidence The document text is titled "Meldepliktig handel for primærinnsider" (Mandatory trading for primary insiders) and details a purchase of shares by Rikard Storvestre, a board member ('styremedlem'), in Navamedic ASA. It explicitly mentions the control of shares and cites the requirement under the Securities Trading Act (§ 5-12). This content directly corresponds to the definition of Director's Dealing (insider trades by directors/executives). Therefore, the appropriate code is DIRS.
2018-10-24 Norwegian
Meldepliktig handel for primærinnsider
Director's Dealing Classification · 100% confidence The document text is titled "Meldepliktig handel for primærinnsider" (Mandatory trading for primary insiders) and details a purchase of shares by an individual (Rikard Storvestre) who is identified as a board member ('styremedlem') of Navamedic ASA. It explicitly mentions compliance with the Securities Trading Act (§ 5-12), which governs insider trading disclosures. This directly corresponds to the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2018-10-23 Norwegian
meldepliktig handel for primærinnsider
Director's Dealing Classification · 98% confidence The document text is very short (449 characters) and reports on a transaction involving a primary insider ('primærinnsider') in Navamedic ASA. Specifically, it states that Rikard Storvestre, a board member ('styremedlem'), bought 12,000 shares. This type of mandatory disclosure regarding personal share transactions by directors and executives directly corresponds to the definition of 'Director's Dealing' (DIRS). It is not a full annual report, earnings release, or a general regulatory announcement fallback.
2018-10-22 Norwegian
Meldepliktig handel for primærinnsider
Director's Dealing Classification · 100% confidence The document text is titled 'Meldepliktig handel for primærinnsider' (Mandatory trading for primary insiders) and details a purchase of shares by an individual identified as a board member ('styremedlem') in Navamedic ASA. It explicitly mentions compliance with the Securities Trading Act (§ 5-12), which governs insider trading disclosures. This directly corresponds to the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2018-10-19 Norwegian
Meldepliktig handel for primærinnsider
Director's Dealing Classification · 100% confidence The document text is very short (475 characters) and reports on a transaction involving shares by a primary insider ('primærinnsider'), specifically a board member ('styremedlem') of Navamedic ASA. The content details the purchase of 10,000 shares and the resulting total holding (30.83%). This directly corresponds to the definition of Director's Dealing (insider trades). Matching against definitions: - DIRS (Director's Dealing): Report of personal share transactions by company directors and executives (insider trades). This is a perfect match. - It is not an ER, IR, 10-K, or AR because it is a specific insider transaction report, not a general financial performance report. - It is not RPA/RNS because it is the primary report of the transaction itself, not an announcement about another report's publication.
2018-10-18 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.